# OCT or Angiography Guided De-escalation of DAPT

> **NCT06339021** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Shenyang Northern Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Optical Coherence Tomography
- Dual Antiplatelet Therapy
- Antiplatelet De-escalation
- Neointimal Coverage
- ST Elevation Myocardial Infarction

## Interventions

- **PROCEDURE:** OCT-guided PCI
- **PROCEDURE:** Conventional angiography-based PCI
- **DRUG:** DAPT de-escalation
- **DRUG:** default DAPT regimen

## Key facts

- **NCT ID:** NCT06339021
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06339021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06339021, "OCT or Angiography Guided De-escalation of DAPT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06339021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*